Analysis of the efficacy and influence factors for treatment of primary hepatocellular carcinoma by Huachansu tablets combined with transarterial chemoembolization

Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 4

Abstract

Objective To evaluate the efficacy of Huachansu tablets combined with transarterial chemoembolization (TACE) for treatment of primary hepatocellular carcinoma (HCC) and prognostic influence factors. Methods One hundred and eight patients with HCC were recruited according to the inclusion and exclusion criteria. Patients were randomly divided into treatment group and control group. The treatment group was treated with Huachansu tablets combined with TACE, and the control group was treated with TACE alone, with overall survival time (OS) and progression-free survival time (PFS) as the evaluation indexes. The COX regression analysis was used to evaluate the survival and prognostic effects and their influence factors in both groups. Results A total of 108 HCC patients were enrolled. The OS was 13.5 months in treatment group and 9.2 months in control group; the PFS was 6.8 months in treatment group and 5.3 months in control group, and the differences were significant statistically (all P<0.05). Multivariate COX regression analysis showed that Child-Pugh grade and cirrhosis were the independent risk factors for PFS in HCC patients. Child-Pugh grade were the independent risk factors for OS in HCC patients. ALBI is a protective factor for OS in HCC patients. Conclusions The treatment of HCC by Huachansu tablets combined with TACE can delay the progression of HCC and prolong PFS and OS of the patients with HCC. Child-Pugh grade, cirrhosis status, and ALBI were important factors affecting the prognosis of the patients with HCC.

Authors and Affiliations

Chienshan CHENG, Tao ZHANG, Junwei WU, Huifeng GAO, Jingxian CHEN, Zhiqiang MENG

Keywords

Related Articles

Retrospective study on sugammadex for reversal of neuromuscular blockade after radiofrequency ablation of hepatic carcinoma under general anesthesia

[Objective] To investigate the effect of sugammadex for reversal of neuromuscular blockade postoperatively in the patients with CT guided radiofrequency ablation of hepatic carcinoma under general anesthesia. [Methods] T...

Advantages and advances in neoadjuvant therapy of pancreatic cancer

Due to the characteristics of the insidious onset, difficult early diagnosis and high malignancy of pancrea-tic cancer, only a minority of patients still have the chance of surgical resection at the time of diagnosis. In...

Study on invasive histopathological features of papillary thyroid carcinoma with tall cell variant

[Objective] To study the invasive histopathological features of papillary thyroid carcinoma(PTC) with tall cell variant(TCV). [Methods] A retrospective analysis of 19 170 cases of PTC in Ruijin Hospital, Shanghai Jia...

Perioperative blood volume monitoring and therapy

Perioperative blood volume monitoring and treatment is an important part of clinical anesthesia, which is essential for restoring effective blood volume, ensuring oxygen supply to organs and tissues, and stabilizing the...

Download PDF file
  • EP ID EP754706
  • DOI 10.16139/j.1007-9610.2024.04.13
  • Views 22
  • Downloads 0

How To Cite

Chienshan CHENG, Tao ZHANG, Junwei WU, Huifeng GAO, Jingxian CHEN, Zhiqiang MENG (2024). Analysis of the efficacy and influence factors for treatment of primary hepatocellular carcinoma by Huachansu tablets combined with transarterial chemoembolization. Journal of Surgery : Concepts & Practice, 29(4), -. https://www.europub.co.uk/articles/-A-754706